Cardiohepatic Syndrome: Liver Injury in Decompensated Heart Failure

Overview

Journal Curr Heart Fail Rep

Publisher Current Science

Date 2014 Jun 4

PMID 24890902

Citations 25

Authors

Said Laribi

Alexandre Mebazaa

Affiliations

Soon will be listed here.

Abstract

Heart failure (HF) is a major healthcare concern. Acute HF carries a high mortality and a high rehospitalisation rate. HF has a variety of detrimental effects on other organs. In recent years, the interactions between heart failure and the kidney have been the subject of significant investigations; this interaction, defined as "cardiorenal syndrome", is relatively well characterized. We describe here another interaction between the heart and the liver, the "cardiohepatic syndrome", in acute HF patients. Recent publications have shown that liver function test (LFT) abnormalities were associated with AHF severity. Clinical signs of systemic congestion were found to be associated with cholestasis, when signs of hypoperfusion were associated with liver cytolysis. Defining the LFT profile in AHF may play an important role in the future management of AHF patients.

Citing Articles

Hepatokines and their role in cardiohepatic interactions in heart failure.

Shouman W, Najmeddine S, Sinno L, Dib Nehme R, Ghawi A, Ziade J Eur J Pharmacol. 2025; 992:177356.

PMID: 39922419 PMC: 11862882. DOI: 10.1016/j.ejphar.2025.177356.

Prognostic Significance of Phenylalanine in Heart Failure: Clinical Insights and Inter-Organ Crosstalk Snapshot.

Yeh J, Tsou Y, Liu M, Chen W, Cheng C, Pan K J Clin Med. 2024; 13(14).

PMID: 39064291 PMC: 11277683. DOI: 10.3390/jcm13144251.

Cannabidiol may prevent the development of congestive hepatopathy secondary to right ventricular hypertrophy associated with pulmonary hypertension in rats.

Krzyzewska A, Baranowska-Kuczko M, Galicka A, Kasacka I, Minczuk K, Kozlowska H Pharmacol Rep. 2024; 76(2):424-434.

PMID: 38519732 PMC: 11016513. DOI: 10.1007/s43440-024-00579-4.

FIB-4 index is associated with mortality in critically ill patients with alcohol use disorder: Analysis from the MIMIC-IV database.

Pan Y, Xia Y, Zhang X, Cai X, Pan J, Dong Y Addict Biol. 2024; 29(2):e13361.

PMID: 38380780 PMC: 10898836. DOI: 10.1111/adb.13361.

Prognostic value of fibrosis-5 index combined with C-reactive protein in patients with acute decompensated heart failure.

Wang Z, Li G, Huang R, Chang L, Gong C, Chen K BMC Cardiovasc Disord. 2023; 23(1):492.

PMID: 37794360 PMC: 10552406. DOI: 10.1186/s12872-023-03530-2.

References

Kubo S, Walter B, JOHN D, Clark M, Cody R . Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med. 1987; 147(7):1227-30. View

Mebazaa A, Gheorghiade M, Pina I, Harjola V, Hollenberg S, Follath F . Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med. 2008; 36(1 Suppl):S129-39. DOI: 10.1097/01.CCM.0000296274.51933.4C. View

Vyskocilova K, Spinarova L, Spinar J, Mikusova T, Vitovec J, Malek J . Prevalence and clinical significance of liver function abnormalities in patients with acute heart failure. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014; 159(3):429-36. DOI: 10.5507/bp.2014.014. View

Allen L, Felker G, Pocock S, McMurray J, Pfeffer M, Swedberg K . Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009; 11(2):170-7. PMC: 2639422. DOI: 10.1093/eurjhf/hfn031. View

Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, Ulmer H . Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Invest. 2011; 42(2):153-63. DOI: 10.1111/j.1365-2362.2011.02573.x. View

Fang J, Mensah G, Croft J, Keenan N . Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008; 52(6):428-34. DOI: 10.1016/j.jacc.2008.03.061. View

Samsky M, Patel C, DeWald T, Smith A, Felker G, Rogers J . Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol. 2013; 61(24):2397-2405. DOI: 10.1016/j.jacc.2013.03.042. View

Mullens W, Abrahams Z, Skouri H, Francis G, Taylor D, Starling R . Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?. J Am Coll Cardiol. 2008; 51(3):300-6. DOI: 10.1016/j.jacc.2007.09.043. View

10.

Smith G, Lichtman J, Bracken M, Shlipak M, Phillips C, DiCapua P . Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006; 47(10):1987-96. DOI: 10.1016/j.jacc.2005.11.084. View

11.

Ambrosy A, Fonarow G, Butler J, Chioncel O, Greene S, Vaduganathan M . The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014; 63(12):1123-1133. DOI: 10.1016/j.jacc.2013.11.053. View

12.

Cruz D, Schmidt-Ott K, Vescovo G, House A, Kellum J, Ronco C . Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013; 182:117-36. DOI: 10.1159/000349968. View

13.

Bagshaw S, Hoste E, Braam B, Briguori C, Kellum J, McCullough P . Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations. Contrib Nephrol. 2013; 182:137-57. DOI: 10.1159/000349971. View

14.

Nieminen M, Harjola V . Definition and epidemiology of acute heart failure syndromes. Am J Cardiol. 2005; 96(6A):5G-10G. DOI: 10.1016/j.amjcard.2005.07.015. View

15.

van Deursen V, Damman K, Hillege H, van Beek A, van Veldhuisen D, Voors A . Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail. 2010; 16(1):84-90. DOI: 10.1016/j.cardfail.2009.08.002. View

16.

Ambrosy A, Vaduganathan M, Huffman M, Khan S, Kwasny M, Fought A . Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail. 2012; 14(3):302-11. DOI: 10.1093/eurjhf/hfs007. View

17.

Mebazaa A . Congestion and cardiorenal syndromes. Contrib Nephrol. 2010; 165:140-144. DOI: 10.1159/000313752. View

18.

Cassidy W, Reynolds T . Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol. 1994; 19(2):118-21. DOI: 10.1097/00004836-199409000-00008. View

19.

Haase M, Muller C, Damman K, Murray P, Kellum J, Ronco C . Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013; 182:99-116. DOI: 10.1159/000349969. View

20.

Batin P, Wickens M, McEntegart D, Fullwood L, Cowley A . The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J. 1995; 16(11):1613-8. DOI: 10.1093/oxfordjournals.eurheartj.a060785. View

21.

Felder L, Mund A, Parker J . Liver function tests in chronic congestive heart failure. Circulation. 1950; 2(2):286-97. DOI: 10.1161/01.cir.2.2.286. View